CeraVe, AcneFree, Ambi acquired by L'Oréal
L'Oréal agreed to acquire CeraVe, AcneFree, Ambi, a skincare brand, on Jan 10, 2017.
Transaction summary
- Target
- CeraVe, AcneFree, Ambi
- Acquirer
- L'Oréal Investor profile →
- Seller
- Valeant Pharmaceuticals
- Announced
- 2017-01-10
- Geography
- -
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-15
- Latest update
- 2026-10-21
Parties at the deal date
Acquirer
Current investor profile →L'Oréal BOLD (Business Opportunities for L'Oréal Development) is L'Oréal's corporate venture capital fund, investing in startups across the beauty value chain including beauty brands, platforms, technology, and science for beauty.
Snapshot preserved for this transaction; current company profiles may differ.
Value and multiples
100% enterprise value
USD 1.3B
100% enterprise value | USD
Basis: FundComb estimate
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
7.7x
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- FundComb’s comps spreadsheet values CeraVe, AcneFree and Ambi at USD 1,300m, used as the whole-company enterprise value, with revenue of USD 169m: 7.7x revenue. The revenue period is not stated. These are FundComb estimates, not confirmed by a public source. Mass Market Retailers reported on 10 January 2017 that L’Oréal bought the three brands from Valeant.
Source summary
L’Oréal buys CeraVe, AcneFree, Ambi brands from Valeant - Mass Market Retailers
ConfirmedContinue your research
Related transaction comps
Aesop acquired by L’Oréal
2023-04-03 · Confirmed
View transaction → Same buyer / investorSkinbetter Science acquired by L’Oréal
2022-09-23 · Confirmed
View transaction → Same sellerObagi Medical Products Business acquired by Haitong International Zhonghua Finance Acquisition Fund I, L.P.
2017-07-01 · Confirmed
View transaction → Acne careHero Cosmetics acquired by Church & Dwight
2022-09-06 · Estimated
View transaction →